Advanced search
Publication Cover
Pharmacogenomics Volume 11, 2010 - Issue 3
Submit an article Journal homepage
687
Views
0
CrossRef citations to date
0
Altmetric
Review

A Current Update on ADHD Pharmacogenomics

Christian Kieling1 ADHD Program, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos, 2350-2201, Porto Alegre, RS, 90035-003, Brazil.View further author information
,
Júlia P Genro2 Department of Genetics, Universidade Federal do Rio Grande do Sul, BrazilView further author information
,
Mara H Hutz2 Department of Genetics, Universidade Federal do Rio Grande do Sul, BrazilView further author information
&
Luis Augusto Rohde1 ADHD Program, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos, 2350-2201, Porto Alegre, RS, 90035-003, Brazil.Correspondence[email protected]
View further author information
Pages 407-419 | Published online: 17 Mar 2010

Bibliography

  • Goldman L , GenelM, BezmanR, SlanetzP: Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA279(14) , 1100–1107 (1998).
  • Kieling C , GoncalvesR, TannockR, CastellanosF: Neurobiology of attention deficit hyperactivity disorder.Child. Adolesc. Psychiatr. Clin. N. Am.17(2) , 285–307, viii (2008).
  • Stein M , McGoughJ: The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.Child. Adolesc. Psychiatr. Clin. N. Am.17(2) , 475–490, xi–xii (2008).
  • Polanczyk G , ZeniC, GenroJ, RomanT, HutzM, RohdeL: Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.Pharmacogenomics6(3) , 225–234 (2005).
  • Vandenbergh D , PersicoA, HawkinsA et al.: Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.Genomics14(4) , 1104–1106 (1992).
  • Gizer I , FicksC, WaldmanI: Candidate gene studies of ADHD: a meta-analytic review.Hum. Genet.126(1) , 51–90 (2009).
  • Winsberg B , ComingsD: Association of the dopamine transporter gene (DAT1) with poor methylphenidate response.J. Am. Acad. Child. Adolesc. Psychiatry38(12) , 1474–1477 (1999).
  • Roman T , SzobotC, MartinsS, BiedermanJ, RohdeL, HutzM: Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.Pharmacogenetics12(6) , 497–499 (2002).
  • Kirley A , LoweN, HawiZ et al.: Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.Am. J. Med. Genet. B. Neuropsychiatr. Genet.121B(1) , 50–54 (2003).
  • Stein M , WaldmanI, SarampoteC et al.: Dopamine transporter genotype and methylphenidate dose response in children with ADHD.Neuropsychopharmacology30(7) , 1374–1382 (2005).
  • van der Meulen E , BakkerS, PaulsD et al.: High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.J. Child. Psychol. Psychiatry46(10) , 1074–1080 (2005).
  • Langley K , TuricD, PeirceT et al.: No support for association between the dopamine transporter (DAT1) gene and ADHD.Am. J. Med. Genet. B. Neuropsychiatr. Genet.139B(1) , 7–10 (2005).
  • McGough J , McCrackenJ, SwansonJ et al.: Pharmacogenetics of methylphenidate response in preschoolers with ADHD.J. Am. Acad. Child. Adolesc. Psychiatry45(11) , 1314–1322 (2006).
  • Zeni C , GuimarãesA, PolanczykG et al.: No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.Am. J. Med. Genet. B. Neuropsychiatr. Genet.144B(3) , 391–394 (2007).
  • Joober R , GrizenkoN, SenguptaS et al.: Dopamine transporter 3´-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Neuropsychopharmacology32(6) , 1370–1376 (2007).
  • Tharoor H , LobosE, ToddR, ReiersenA: Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(4) , 527–530 (2008).
  • Kereszturi E , TarnokZ, BognarE et al.: Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(8) , 1431–1435 (2008).
  • Purper-Ouakil D , WohlM, OrejarenaS et al.: Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(8) , 1425–1430 (2008).
  • Gruber R , JooberR, GrizenkoN, LeventhalB, CookEJ, SteinM: Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.J. Child. Adolesc. Psychopharmacol.19(3) , 233–239 (2009).
  • Leddy J , WaxmonskyJ, SalisR et al.: Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.J. Child. Adolesc. Psychopharmacol.19(2) , 127–136 (2009).
  • McGough J , McCrackenJ, LooS et al.: A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.J. Am. Acad. Child. Adolesc. Psychiatry (2009) (Epub ahead of print).
  • Mick E , BiedermanJ, SpencerT, FaraoneS, SklarP: Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.Am. J. Med. Genet. B. Neuropsychiatr. Genet.141B(8) , 890–894 (2006).
  • Kooij J , BoonstraA, VermeulenS et al.: Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(2) , 201–208 (2008).
  • Rohde L , RomanT, SzobotC, CunhaR, HutzM, BiedermanJ: Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.Synapse48(2) , 87–89 (2003).
  • Cheon K , RyuY, KimJ, ChoD: The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.Eur. Neuropsychopharmacol.15(1) , 95–101 (2005).
  • Loo S , SpecterE, SmolenA, HopferC, TealeP, ReiteM: Functional effects of the DAT1 polymorphism on EEG measures in ADHD.J. Am. Acad. Child. Adolesc. Psychiatry42(8) , 986–993 (2003).
  • Bellgrove M , HawiZ, KirleyA, FitzgeraldM, GillM, RobertsonI: Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.Neuropsychopharmacology30(12) , 2290–2297 (2005).
  • Gilbert D , WangZ, SalleeF et al.: Dopamine transporter genotype influences the physiological response to medication in ADHD.Brain129(Pt 8) , 2038–2046 (2006).
  • Oldenhof J , VickeryR, AnafiM et al.: SH3 binding domains in the dopamine D4 receptor.Biochemistry37(45) , 15726–15736 (1998).
  • Gelernter J , KennedyJ, van Tol H, Civelli O, Kidd K: The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics13(1) , 208–210 (1992).
  • Tahir E , YazganY, CirakogluB, OzbayF, WaldmanI, AshersonP: Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.Mol. Psychiatry5(4) , 396–404 (2000).
  • Seeger G , SchlossP, SchmidtM: Marker gene polymorphisms in hyperkinetic disorder – predictors of clinical response to treatment with methylphenidate?Neurosci. Lett.313(1–2) , 45–48 (2001).
  • Hamarman S , FossellaJ, UlgerC, BrimacombeM, DermodyJ: Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.J. Child. Adolesc. Psychopharmacol.14(4) , 564–574 (2004).
  • Cheon K , KimB, ChoS: Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children.Neuropsychopharmacology32(6) , 1377–1383 (2007).
  • Hoehe M , OtterudB, HsiehW et al.: Genetic mapping of adrenergic receptor genes in humans.J. Mol. Med.73(6) , 299–306 (1995).
  • Polanczyk G , ZeniC, GenroJ et al.: Association of the adrenergic a2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.Arch. Gen. Psychiatry64(2) , 218–224 (2007).
  • da Silva T , PiancaT, RomanT et al.: Adrenergic α2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.J. Neural. Transm.115(2) , 341–345 (2008).
  • Cheon K , ChoD, KooM, SongD, NamkoongK: Association between homozygosity of a G allele of the α-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.Biol. Psychiatry65(7) , 564–570 (2009).
  • Arnsten A : Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.CNS Drugs23(Suppl. 1) , 33–41 (2009).
  • Stevenson J , LangleyK, PayH et al.: Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene.J. Child. Psychol. Psychiatry46(10) , 1081–1088 (2005).
  • Keulers E , HendriksenJ, FeronF et al.: Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.Eur. J. Paediatr. Neurol.11(1) , 21–28 (2007).
  • Lotta T , VidgrenJ, TilgmannC et al.: Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.Biochemistry34(13) , 4202–4210 (1995).
  • Cheon K , JunJ, ChoD: Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.Int. Clin. Psychopharmacol.23(5) , 291–298 (2008).
  • Sengupta S , GrizenkoN, SchmitzN et al.: COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.Neuropsychopharmacology33(13) , 3069–3077 (2008).
  • Mick E , NealeB, MiddletonF, McGoughJ, FaraoneS: Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(8) , 1412–1418 (2008).
  • Yang L , WangY, LiJ, FaraoneS: Association of norepinephrine transporter gene with methylphenidate response.J. Am. Acad. Child. Adolesc. Psychiatry43(9) , 1154–1158 (2004).
  • Manor I , LaibaE, EisenbergJ et al.: Association between tryptophan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants.Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(8) , 1501–1508 (2008).
  • Sinzig J , DöpfnerM, LehmkuhlG et al.: Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.J. Child. Adolesc. Psychopharmacol.17(4) , 421–432 (2007).
  • Guimarães A , ZeniC, PolanczykG et al.: MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder.Int. J. Neuropsychopharmacol.12(5) , 709–714 (2009).
  • Zhu H , PatrickK, YuanH et al.: Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.Am. J. Hum. Genet.82(6) , 1241–1248 (2008).
  • Nemoda Z , AngyalN, TarnokZ, GadorosJ, Sasvari-SzekelyM: Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.Neuropharmacology57(7–8) , 731–733 (2009).
  • Michelson D , FariesD, WernickeJ et al.: Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose–response study.Pediatrics108(5) , E83 (2001).
  • Michelson D , ReadH, RuffD, WitcherJ, ZhangS, McCrackenJ: CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.J. Am. Acad. Child. Adolesc. Psychiatry46(2) , 242–251 (2007).
  • Trzepacz P , WilliamsD, FeldmanP, WrishkoR, WitcherJ, BuitelaarJ: CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD.Eur. Neuropsychopharmacol.18(2) , 79–86 (2008).
  • Ramoz N , BoniC, DowningA et al.: A haplotype of the norepinephrine transporter (Net) gene SLC6A2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).Neuropsychopharmacology34(9) , 2135–2142 (2009).
  • Altman D : Better reporting of randomised controlled trials: the CONSORT statement.BMJ313(7057) , 570–571 (1996).
  • Everitt B , WesselyS: Clinical Trials in Psychiatry. John Wiley & Sons, NJ, USA (2008).
  • Polanczyk G , FaraoneS, BauC et al.: The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents.Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(8) , 1419–1424 (2008).
  • Kieling C , RohdeL: Challenges and opportunities in ADHD pharmacogenomics.Pharmacogenomics9(9) , 1193–1194 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.